SCM
TBRA

Stonepine Capital Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Stonepine Capital Management’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-733,718
Closed -$29.2M – 26
2016
Q3 		$29.2M Buy
733,718
+96,151
+15% +$1.07M 23.78% 1
2016
Q2 		$8.01M Sell
637,567
-195,410
-23% -$1.82M 8.21% 5
2016
Q1 		$6.81M Sell
832,977
-400
-0% -$3.02K 8.04% 5
2015
Q4 		$8.38M Buy
+833,377
New +$8.66M 9.81% 4

Stonepine Capital Management's TBRA Position: Q4 2016 in Review

Stonepine Capital Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 733,718 shares — an estimated $29.2M sold.

Stonepine Capital Management first reported a position in TBRA in Q4 2015 and held it in 4 quarters. The position peaked at $29.2M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • Stonepine Capital Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Stonepine Capital Management sold 733,718 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $29.2M.
  • Stonepine Capital Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
  • Stonepine Capital Management's Tobira Therapeutics, Inc. Common Stock position peaked at $29.2M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Stonepine Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.